retatrutide peptide reviews Since January 2026, there have been six cases of acute liver toxicity associated with unapproved products labelled in Australia. These toxic effects may be linked to a contaminant in the Retatrutide Peptide for Weight Loss,

A recent study published in the Journal of the American Medical Association by Dr

GLP-1 for sleep apnea, alcohol use and cancer risk GLP-1s may address conditions well beyond metabolic diseases: Obstructive sleep apnea: Emerging data suggest GLP-1s improve apnea symptoms. Alcohol use disorder: Patients using liraglutide or semaglutide reduced alcohol consumption by nearly two-thirds. Obesity-related cancers: An observational study of 6,000 adults found that GLP-1 receptor agonists halved the risk of obesity-related cancers compared with usual care

GLP-1 medications may lower blood pressure through weight loss and improved glycemic control, creating a potential balancing effect

Parent trades on NYSE as HIMS

Trulicity and Blood Clots Some GLP-1 agonist drugs have been tied to an increased risk of a type of blood clot called a deep vein thrombosis

Eating smaller, more frequent meals can also promote the medications efficacy